Thomas Biermeyer

Director - Dr. - LLM - Avocat à la Cour

Contact me now

_Dr. Thomas Biermeyer, Director, advises companies, entrepreneurs as well as investors on cross-border public and private M&A, restructuring and financing operations and has obtained relevant experience in many sectors with a particular focus on biotech, energy and telecommunications. Thomas also acts in a range of complex cross-border corporate and financial litigation cases with a specific focus on shareholder disputes.

Thomas is also Assistant Professor at Maastricht University, where he teaches and researches European corporate finance law. He frequently collaborates with the European Commission and the European Parliament on different studies on EU company law. His main academic focus is empirical research on corporate mobility as well as on corporate finance structures by means of data science.

He previously worked for a renowned international law firm in France and in Luxembourg, a law firm in the Netherlands and an international legal consultancy in Brussels.

Thomas has been a member of the Luxembourg Bar since 2016.

Academic background:

  • Doctorate degree (PhD) in EU and Comparative Corporate Law (Maastricht University - The Netherlands),
  • Visiting Researcher (Paris-Sorbonne University - France),
  • Visiting Researcher (Harvard Law School - United States),
  • Visiting Researcher (Oxford University - United Kingdom),
  • Master (LLM), European Law School (Maastricht University - The Netherlands),
  • Bachelor (LLB), European Law School (Maastricht University - The Netherlands),
  • Bachelor in European Studies (BA) (Maastricht University - The Netherlands).

Related Publications

Parts bénéficiaires
article 14 July 2021

Parts bénéficiaires – Ein innovatives und anpassungsfähiges Instrument für Private Equity und andere Finanzstrukturen in und aus Luxemburg

_Luxemburg, als europäisches Zentrum der Finanzwirtschaft, bietet internationalen Akteuren bekanntlich eine Vielzahl an Möglichkeiten, um ihre Wünsche in Einklang mit den regulatorischen Bestimmungen ...

See all insights

Related Events

See all events